David P. Meeker
2020
In 2020, David P. Meeker earned a total compensation of $14.3M as Chief Executive Officer at RHYTHM PHARMACEUTICALS.
Compensation breakdown
Non-Equity Incentive Plan | $207,958 |
---|---|
Option Awards | $12,844,897 |
Salary | $262,308 |
Stock Awards | $918,500 |
Other | $43,704 |
Total | $14,277,367 |
Meeker received $12.8M in option awards, accounting for 90% of the total pay in 2020.
Meeker also received $208K in non-equity incentive plan, $262.3K in salary, $918.5K in stock awards and $43.7K in other compensation.
Rankings
In 2020, David P. Meeker's compensation ranked 446th out of 13,090 executives tracked by ExecPay. In other words, Meeker earned more than 96.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 446 out of 13,090 | 97th |
Division Manufacturing | 152 out of 5,624 | 97th |
Major group Chemicals And Allied Products | 51 out of 2,257 | 98th |
Industry group Drugs | 45 out of 1,957 | 98th |
Industry Pharmaceutical Preparations | 32 out of 1,462 | 98th |
Source: SEC filing on April 27, 2023.
Meeker's colleagues
We found two more compensation records of executives who worked with David P. Meeker at RHYTHM PHARMACEUTICALS in 2020.